Durham-based Pharmaceuticals and Biotechnology company Novan Inc. (NOVN:NAQ) sees value rise 27.8% in week ending June 4

0Comments

Value in Pharmaceuticals and Biotechnology stocks fell 0.2 percent in the week ending June 4 from the previous week.

The strongest performing Pharmaceuticals and Biotechnology company in North Carolina was VTv Therapeutics Inc. (VTVT:NAQ), sitting 761.9 percent higher to sell at $0.71.

SCYNEXIS Inc. (SCYX:NMQ) fared the worst among North Carolina companies, suffering a 61.6 percent drop to $2.09.

Among Durham companies, Novan Inc. (NOVN:NAQ) saw the highest rise in value of 27.8 percent in the week ending June 4.

The Finance and Credit Services industry was the week’s best-performing industry on the market. The market is divided into 44 different industries.

Beverages was the worst-performing industry.

Healthcare and technology stocks are viewed as the safest bets for long-term gains.

Besty Kuekcer with Benzinga.com said healthcare-related stocks, such as hospital conglomerates and insurance companies, have weathered numerous economic crises and still make a profit, suggesting that they are generally a stable investment.

While technology stocks can be more risky, given the boom-bust nature of new tech companies, Kuecker recommended a diverse portfolio of tech companies to strike it big when companies succeed or sell to other larger companies.

For short-term investments, Kuecker recommended “consumer discretionary” stocks, which are sensitive to economic changes but can rise greatly on the back of a strong economy.

Nothing in this article is to be assumed as financial advice.

Rank of stock market industries in week ending June 4

Industry Percentage Change Highest Positive Change Largest Negative Change
Finance and Credit Services 94.3% 57.9% -98%
Alternative Energy 7.5% 103.8% -89.8%
Medical Equipment and Services 5.8% 4,727% -91.8%
Oil, Gas and Coal 2.5% 13,440.6% -99.3%
Personal Goods 2.2% 5,396% -84.7%
Electronic and Electrical Equipment 2% 492,344.9% -99.2%
Travel and Leisure 1.5% 1,646% -92.7%
Consumer Services 1.3% 960.4% -91%
Industrial Transportation 1.1% 165.6% -67.3%
Industrial Engineering 0.8% 3,444.6% -92.7%
Industrial Materials 0.4% 48.1% -68.4%
Aerospace and Defense 0.3% 766.5% -89.4%
General Industrials 0.3% 130.2% -76.9%
Waste and Disposal Services 0.3% 725% -60.4%
Automobiles and Parts 0.2% 20,959.3% -91.2%
Industrial Metals and Mining 0.2% 100% -99.7%
Telecommunications Service Providers -0.1% 123.5% -99.5%
Pharmaceuticals and Biotechnology -0.2% 19,638.8% -95.8%
Precious Metals and Mining -0.3% 559.5% -67.9%
Industrial Support Services -0.3% 1,299.6% -95%
Closed End Investments -0.4% 741.2% -93%
Mortgage Real Estate Investment Trusts -0.5% 1,335.5% -72.5%
Technology Hardware and Equipment -0.5% 138.4% -88.9%
Retailers -0.6% 416.7% -93.5%
Non-life Insurance -0.7% 448% -89.3%
Gas, Water and Multi-utilities -0.7% 142.9% -89.3%
Software and Computer Services -0.8% 7,766.9% -98.6%
Banks -0.8% 2,408.7% -98.5%
Electricity -0.9% 138.8% -77.4%
Real Estate Investment Trusts -1.1% 920.5% -86%
Chemicals -1.2% 104.7% -97.5%
Tobacco -1.3% 2,339% -35.7%
Media -2% 5,075% -90.7%
Life Insurance -2.1% 219.3% -94%
Food Producers -2.1% 55,624,900% -98.8%
Investment Banking and Brokerage Services -2.3% 125,672.4% -99.3%
Telecommunications Equipment -2.8% 579.6% -99.6%
Personal Care, Drug and Grocery Stores -2.8% 327.9% -67.9%
Household Goods and Home Construction -2.9% 13,329.4% -83.1%
Health Care Providers -3% 222.1% -97.4%
Real Estate Investment and Services -4.3% 1,132.5% -92.9%
Construction and Materials -4.6% 759.7% -80.6%
Leisure Goods -4.6% 131.8% -93.2%
Beverages -19.7% 1,721.9% -97.7%


Related

Craig T. Albanese, CEO

Duke Health trial finds immunotherapy delays chemotherapy in advanced colorectal cancer

A new clinical trial from Duke Health shows that first-line immunotherapy may delay or replace chemotherapy in advanced colorectal cancer cases. The findings offer hope for improved quality of life among younger patients facing aggressive forms of the disease.

Hannah Lohman, RTI Research Environmental Engineer

EPA and HHS announce actions to address microplastics in drinking water

The EPA and HHS have announced new efforts targeting microplastics in U.S. drinking water systems. RTI International staff attended as federal officials detailed regulatory plans prioritizing research funding into detection methods, impacts on health, prevention strategies, and laboratory standards.

Tim J. Gabel, President and Chief Executive Officer

RTI International examines trends and shifts in ultra-processed food consumption

RTI International highlights rising consumer awareness about ultra-processed foods (UPFs) alongside industry reformulations and emerging state-level policies restricting certain additives. The organization points out challenges surrounding inconsistent definitions while noting increased calls for transparency from both regulators and public health advocates.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Durham Reporter.